Open AccessPCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Hyperglycemic Mice Increases the Risk of Hemorrhagic Transformation of Ischemic Stroke
Author(s) -
Brice Nativel,
Stéphane RaminMangata,
C. David,
Cynthia Planesse,
Mathias Roche,
Antonio Gallo,
Olivier Meilhac,
Gilles Lambert,
Steeve Bourane
Publication year - 2021
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.121.035677
Subject(s) - medicine , kexin , pcsk9 , proprotein convertase , subtilisin , proprotein convertases , stroke (engine) , ischemic stroke , endocrinology , ldl receptor , cholesterol , ischemia , lipoprotein , biochemistry , enzyme , mechanical engineering , chemistry , engineering
[Figure: see text].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom